Sheri L. Dodd is the Chief Executive Officer of Tactile Systems Technology Inc., a medical technology company focused on developing and providing innovative solutions for chronic conditions such as lymphedema and chronic venous insufficiency. With an extensive background in the healthcare industry, Dodd has demonstrated a strong commitment to improving patient care through the use of advanced medical technologies. Before joining Tactile Systems Technology, she held leadership positions at several prominent healthcare organizations, including as President of the Patient Monitoring and Respiratory Interventions business at Medtronic. In her role as CEO at Tactile Systems Technology, Dodd has been instrumental in driving the company's growth and success. Under her leadership, the company has expanded its product offerings and strengthened its position in the market. Dodd's strategic vision and dedication to innovation have been key factors in the company's ability to develop and deliver cutting-edge solutions that improve the quality of life for patients with chronic conditions. Her focus on patient-centric care and commitment to excellence have earned her recognition within the industry and among her peers. Dodd's achievements extend beyond her work at Tactile Systems Technology. She is an active member of several professional organizations and has been recognized for her contributions to the healthcare industry. Dodd's leadership and expertise have been instrumental in shaping the future of medical technology and improving patient outcomes. As CEO of Tactile Systems Technology, she continues to lead the company in its mission to provide innovative solutions that enhance the lives of patients worldwide.